- Home
- GOSS vs PMM Comparison
GOSS vs PMM Comparison
Compare GOSS & PMM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GOSS
- PMM
- Stock Information
- Founded
- GOSS 2015
- PMM 1989
- Country
- GOSS United States
- PMM United States
- Employees
- GOSS N/A
- PMM N/A
- Industry
- GOSS Biotechnology: Pharmaceutical Preparations
- PMM Investment Managers
- Sector
- GOSS Health Care
- PMM Finance
- Exchange
- GOSS Nasdaq
- PMM Nasdaq
- Market Cap
- GOSS 237.9M
- PMM 273.8M
- IPO Year
- GOSS 2019
- PMM N/A
- Fundamental
- Price
- GOSS $0.96
- PMM $6.14
- Analyst Decision
- GOSS Strong Buy
- PMM
- Analyst Count
- GOSS 5
- PMM 0
- Target Price
- GOSS $9.20
- PMM N/A
- AVG Volume (30 Days)
- GOSS 1.0M
- PMM 118.3K
- Earning Date
- GOSS 03-04-2025
- PMM 01-01-0001
- Dividend Yield
- GOSS N/A
- PMM 4.68%
- EPS Growth
- GOSS N/A
- PMM N/A
- EPS
- GOSS N/A
- PMM 0.23
- Revenue
- GOSS $105,322,000.00
- PMM N/A
- Revenue This Year
- GOSS N/A
- PMM N/A
- Revenue Next Year
- GOSS N/A
- PMM N/A
- P/E Ratio
- GOSS N/A
- PMM $26.52
- Revenue Growth
- GOSS N/A
- PMM N/A
- 52 Week Low
- GOSS $0.50
- PMM $5.00
- 52 Week High
- GOSS $1.60
- PMM $6.42
- Technical
- Relative Strength Index (RSI)
- GOSS 54.23
- PMM 53.13
- Support Level
- GOSS $0.83
- PMM $5.98
- Resistance Level
- GOSS $1.18
- PMM $6.10
- Average True Range (ATR)
- GOSS 0.10
- PMM 0.06
- MACD
- GOSS -0.01
- PMM 0.02
- Stochastic Oscillator
- GOSS 41.37
- PMM 95.24
About GOSS Gossamer Bio Inc.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.
About PMM Putnam Managed Municipal Income Trust
Putnam Managed Municipal Income Trust is a closed-end management investment company. Its investment objective is to seek a high level of current income exempt from federal income tax by investing in a diversified portfolio of tax-exempt municipal securities. The Fund invests in various sectors such as healthcare, retirement community, private higher education, housing-backed, essential service utilities, and state-backed bonds.